E-LIB Suche - Ergebnisse für: Reichard, Holly A.

1

First-Time Disclosure of CVN424, a Potent and Selective GPR..:

Sun, Huikai ; Monenschein, Holger ; Schiffer, Hans H....
Journal of Medicinal Chemistry. 64 (2021) 14 - p. 9875-9890 , 2021

Link: https://doi.org/10.1021/..

2

Discovery of TAK-041: a Potent and Selective GPR139 Agonist..:

Reichard, Holly A. ; Schiffer, Hans H. ; Monenschein, Holger...
Journal of Medicinal Chemistry. 64 (2021) 15 - p. 11527-11542 , 2021

Link: https://doi.org/10.1021/..

3

S180. THE SELECTIVE GPR139 AGONIST TAK-041 REVERSES ANHEDON..:

Hodgson, Robert ; Corbett, Ged ; Hitchcock, Steve...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S106-S107 , 2020

Link: https://doi.org/10.1093/..

4

In Vitro Biotransformation of the Nrf2 Activator Bardoxolon..:

Kamel, Amin M. ; Bowlin, Stephen ; Anwar, Ban...
Chemical Research in Toxicology. 32 (2019) 11 - p. 2268-2280 , 2019

Link: https://doi.org/10.1021/..

5

S39. GPR139 AN OPHAN GPCR AFFECTING NEGATIVE DOMAINS OF SCH..:

Atienza, Joy ; Reichard, Holly ; Mulligan, Victoria...
Schizophrenia Bulletin. 44 (2018) suppl_1 - p. S339-S339 , 2018

Link: https://doi.org/10.1093/..

6

Asymmetric Synthesis of Dihydroindanes by Convergent Alkoxi..:

Greszler, Stephen N. ; Reichard, Holly A. ; Micalizio, Glenn C.
Journal of the American Chemical Society. 134 (2012) 5 - p. 2766-2774 , 2012

Link: https://doi.org/10.1021/..

7

Metallacycle-mediated cross-coupling with substituted and e..:

Reichard, Holly A. ; Micalizio, Glenn C.
Chem. Sci.. 2 (2011) 4 - p. 573-589 , 2011

Link: https://doi.org/10.1039/..

8

Regioselective Reductive Cross‐Coupling Reactions of Unsymm..:

Reichard, Holly A. ; McLaughlin, Martin ; Chen, Ming Z..
European Journal of Organic Chemistry. 2010 (2010) 3 - p. 391-409 , 2010

Link: https://doi.org/10.1002/..

9

In vitro Biotransformation of the Nrf2 activator Bardoxolon..:

Kamel, Amin M ; Bowlin, Stephen ; Anwar, Ban...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487086/. , 2019

Link: http://www.ncbi.nlm.nih...

10

Asymmetric Synthesis of Dihydroindanes by Convergent Alkoxi..:

Greszler, Stephen N ; Reichard, Holly A ; Micalizio, Glenn C
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275653. , 2012

Link: http://www.ncbi.nlm.nih...

11

Metallacycle-Mediated Cross-Coupling with Substituted and E..:

Reichard, Holly A ; Micalizio, Glenn C
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061465. , 2011

Link: http://www.ncbi.nlm.nih...

12

Regioselective Reductive Cross-Coupling Reactions of Unsymm..:

Reichard, Holly A ; McLaughlin, Martin ; Chen, Ming Z.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951371. , 2010

Link: http://www.ncbi.nlm.nih...

13

Discovery of TAK-041: a Potent and Selective GPR139 Agonist..:

Holly A. Reichard (2115589) ; Hans H. Schiffer (10660697) ; Holger Monenschein (1822072)...
https://figshare.com/articles/dataset/Discovery_of_TAK-041_a_Potent_and_Selective_GPR139_Agonist_Explored_for_the_Treatment_of_Negative_Symptoms_Associated_with_Schizophrenia/14983813. , 2021

Link: https://doi.org/10.1021/..

14

First-Time Disclosure of CVN424, a Potent and Selective GPR..:

Huikai Sun (2037619) ; Holger Monenschein (1822072) ; Hans H. Schiffer (10660697)...
https://figshare.com/articles/dataset/First-Time_Disclosure_of_CVN424_a_Potent_and_Selective_GPR6_Inverse_Agonist_for_the_Treatment_of_Parkinson_s_Disease_Discovery_Pharmacological_Validation_and_Identification_of_a_Clinical_Candidate/14439413. , 2021

Link: https://doi.org/10.1021/..

15

Discovery of TAK-041: a Potent and Selective GPR139 Agonist..:

Holly A. Reichard (2115589) ; Hans H. Schiffer (10660697) ; Holger Monenschein (1822072)...
https://figshare.com/articles/journal_contribution/Discovery_of_TAK-041_a_Potent_and_Selective_GPR139_Agonist_Explored_for_the_Treatment_of_Negative_Symptoms_Associated_with_Schizophrenia/14983816. , 2021

Link: https://doi.org/10.1021/..